Squarepoint’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.7M | Sell |
68,900
-570
| -0.8% | -$138K | 0.02% | 444 |
|
2025
Q1 | $18.9M | Sell |
69,470
-106
| -0.2% | -$28.9K | 0.02% | 378 |
|
2024
Q4 | $12.9M | Sell |
69,576
-3,133
| -4% | -$579K | 0.01% | 469 |
|
2024
Q3 | $16.3M | Buy |
72,709
+654
| +0.9% | +$147K | 0.03% | 349 |
|
2024
Q2 | $10.3M | Buy |
72,055
+1,743
| +2% | +$249K | 0.02% | 462 |
|
2024
Q1 | $11M | Buy |
70,312
+49,320
| +235% | +$7.71M | 0.02% | 446 |
|
2023
Q4 | $3.79M | Buy |
20,992
+19,473
| +1,282% | +$3.51M | 0.01% | 769 |
|
2023
Q3 | $273K | Sell |
1,519
-6,921
| -82% | -$1.24M | ﹤0.01% | 1982 |
|
2023
Q2 | $1.5M | Buy |
8,440
+4,594
| +119% | +$819K | ﹤0.01% | 1041 |
|
2023
Q1 | $829K | Buy |
+3,846
| New | +$829K | ﹤0.01% | 1252 |
|
2022
Q4 | – | Sell |
-2,400
| Closed | -$324K | – | 2686 |
|
2022
Q3 | $324K | Sell |
2,400
-1,741
| -42% | -$235K | ﹤0.01% | 1590 |
|
2022
Q2 | $670K | Buy |
4,141
+1,931
| +87% | +$312K | ﹤0.01% | 1240 |
|
2022
Q1 | $417K | Buy |
2,210
+13
| +0.6% | +$2.45K | ﹤0.01% | 1581 |
|
2021
Q4 | $595K | Buy |
2,197
+268
| +14% | +$72.6K | ﹤0.01% | 1497 |
|
2021
Q3 | $700K | Sell |
1,929
-5,342
| -73% | -$1.94M | ﹤0.01% | 1228 |
|
2021
Q2 | $2.5M | Buy |
+7,271
| New | +$2.5M | 0.01% | 714 |
|
2020
Q4 | – | Sell |
-1,961
| Closed | -$562K | – | 2934 |
|
2020
Q3 | $562K | Buy |
+1,961
| New | +$562K | 0.01% | 1278 |
|
2020
Q1 | – | Sell |
-2,450
| Closed | -$406K | – | 2550 |
|
2019
Q4 | $406K | Buy |
+2,450
| New | +$406K | ﹤0.01% | 1834 |
|
2019
Q3 | – | Sell |
-4,179
| Closed | -$518K | – | 2598 |
|
2019
Q2 | $518K | Buy |
+4,179
| New | +$518K | 0.01% | 1607 |
|
2018
Q4 | – | Sell |
-1,657
| Closed | -$285K | – | 2273 |
|
2018
Q3 | $285K | Buy |
+1,657
| New | +$285K | ﹤0.01% | 1563 |
|
2017
Q4 | – | Sell |
-3,137
| Closed | -$325K | – | 2370 |
|
2017
Q3 | $325K | Buy |
+3,137
| New | +$325K | 0.01% | 1125 |
|